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Abstract
The production of effective drugs has continuously been a challenging process
for researchers due to the occurrence of resistive diseases. Drugs derived from
natural product-based compounds as an active scaffold have gained interest
in drug development due to a wide range of biological properties. Ben-
zoheterodiazepines, a natural product derivative of bicyclic chalcones have been
widely reported with various therapeutic potentials. This review discusses current
synthetic methods in the preparation of benzoheterodiazepine derivatives
(i.e., homocyclic benzoheterodiazepine, heterocyclic benzoheterodiazepine, bis-
benzoheterodiazepine, and fused benzoheterodiazepine) via two-pot and one-pot
synthetic routes. Several reaction protocols following both synthetic routes have
been developed for efficient and higher yields that offer access to different func-
tionalization of benzoheterodiazepines are comprehensively described. This
review is important in the heterocyclic chemistry of benzoheterodiazepines and
pharmacological industries in drug development processes.
1 | INTRODUCTION
Chalcone is a natural product [1] and bio-active [2,3] mole-
cule that frequently used in the synthesis of heterocyclic
compounds that is, pyrazole [4], imidazole [5,6], epoxide [7],
benzodiazepine [8], pyrimidine [9], indole [10], flavone [11],
isoflavone [12], and pyrazoline [13–15]. Chalcone-derived
heterocyclic compounds consist of heteroatomic atoms
(i.e., oxygen, sulfur, and nitrogen), which remarkable in the
medicinal field for excellent activities in drug design [16–18].
Benzoheterodiazepine is a seven-membered heterocyclic
ring [19] with two heteroatoms [20], nonplanar [21], and
pharmacophoric [22,23] properties. Benzodiazepines and
benzothiazepines are examples of benzoheterodiazepine
derivatives that are commercially used in medicine such as
nevirapine [24], fuligocandin B [25], tiazesim [26], hala-
zepam [27], diltiazem [28], triazolam [29], gastrozepin [30],
clozapine (a) [31], olanazapine (b) [32], 3-carbamoyl-1,-
5-benzodiazapine (c), clobazam (antiepileptic agent), (d)
and neoplasm inhibitors (e) (Figure 1) [31,33].
Benzodiazepines and benzothiazepines played a
prominent role in drug research during the last three
decades [34]. Their derivatives are also equally significant
in pharmaceutical applications with a wide spectrum of
biological properties such as antiinfectives [35], antiar-
rhythmic [36], anthelmintic [37], anticancer [38–42],
antifidant [43], antihypnotic [44], antihypertensive [45],
anticonvulsant [46,47], antioxidant [48,49], antidiabetic
[50], antiHIV [24,51,52], antifungal [53], antidepressant
[54], antimicrobial [55], antituberculosis [18], antineo-
plastics [56], anti-inflammatory [57] as well as inhibitors
for cholinesterase [58] and neurological disorders [59].
Benzoheterodiazepine derivatives have also been
reported as corrosion inhibitors [60], dyes for the acrylic
fibers [57] in photography, photographic emulsions [61],
and lubricating oil with antioxidant properties [62]. The
1,5-benzodiazepine is the active chromophore of ben-
zoheterodiazepines against different types of targets
including interleukin converting enzymes, peptide hor-
mones, and potassium blockers [63].
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3 | CONCLUSION
Benzoheterodiazepines are one of the heterocyclic com-
pounds with reactive pharmacophore and a wide range of
biological properties. Researchers are tirelessly working
around the clock in designing and modifying ben-
zoheterodiazepines nucleus to produce series of effective
drugs. This updated review article is based upon the
chalcone-derived benzoheterodiazepines synthetic routes
(i.e., one-pot and two-pot) and their applications. Two-pot
is commonly used with several advantages such as less sol-
vent usage, good purity of desired product, and a lower rate
of side product formations compared to one-pot synthetic
methodology. Nevertheless, the one-pot synthetic route
offers a faster reaction with no purification step of interme-
diates involved. The assembled information regarding
chalcone-derived benzoheterodiazepine synthesis and its
applications is significant among synthetic chemists and
pharmacists in designing drugs with fascinating medicinal
properties.
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R1 = Cl, OCH3, OH;

















Toluene, heating (9 h)
90-95 %
SCHEME 18 One-pot synthesis of
benzoheterodiazepine derivatives
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